Myelofibrosis in primary myelodysplastic syndromes: Clinical and Biological Significance

By Marisavljević D.   Rolović Z.   Ćemerikić V.   Bošković D.   Ćolović M.  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 325-331

Humana Press, Inc

Access to resources Recommend Favorite

Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes

By Marisavljević D.   Rolović Z.   Šefer D.   Basara N.   Ilić D.   Bošković D.   Čolović M.  

Medical Oncology, Vol. 19, Iss. 4, 2002-12 ,pp. : 249-259

Humana Press, Inc

Access to resources Recommend Favorite

Long-term survivors in myelodysplastic syndromes: Clinical and biological characteristics

By Marisavljević Dragomir   Rolović Zoran   Bošković Darinka   Čolović Milica  

Medical Oncology, Vol. 21, Iss. 4, 2004-12 ,pp. : 333-338

Humana Press, Inc

Access to resources Recommend Favorite

Immunologic Abnormalities in Myelodysplastic Syndromes: Clinical Features and Characteristics of the Lymphoid Population

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 385-392

Humana Press, Inc

Access to resources Recommend Favorite

Hypocellular myelodysplastic syndrome with myelofibrosis in acute myeloid leukemia transformation: A case report

By      

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 422-424

Spandidos Publications

Access to resources Recommend Favorite